...
首页> 外文期刊>Archiv der Pharmazie >Ursolic acid: Pharmacokinetics process in vitro in vitro and in vivo in vivo , a mini review
【24h】

Ursolic acid: Pharmacokinetics process in vitro in vitro and in vivo in vivo , a mini review

机译:Ursolic acid:体外体外和体内体外的药代动力学过程,迷你评论

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Ursolic acid (UA) is a natural triterpene compound found in various fruits and vegetables. UA has a widespread pharmacologic effect, including antitumor, anti‐inflammatory, anti‐oxidant, anti‐apoptotic, anti‐allergy, and anti‐carcinogenic effects. UA can be used as an alternative medicine for the treatment and prevention of many diseases. However, the bioavailability of UA by oral administration is low since it is absorbed by the intestine through passive diffusion. Therefore, some novel technologies are used to produce UA preparations that can change the pharmacokinetics process and increase its solubility and bioavailability. At present, pharmacokinetic studies on UA are few. In this paper, we will review the pharmacokinetics features of free UA and some novel UA preparations in vitro and in vivo , in order to provide a reference for rational utilization and drug design of UA.
机译:摘要熊胆酸(UA)是在各种水果和蔬菜中发现的天然三萜化合物。 UA具有广泛的药理学作用,包括抗肿瘤,抗炎,抗氧化剂,抗凋亡,抗过敏和抗致癌作用。 UA可作为替代药物用于治疗和预防许多疾病。 然而,口服给药的UA的生物利用度低,因为它通过被动扩散被肠道吸收。 因此,一些新型技术用于生产可以改变药代动力学过程的UA制剂,并增加其溶解度和生物利用度。 目前,对UA的药代动力学研究很少。 在本文中,我们将在体外和体内审查免费UA和一些新型UA制剂的药代动力学特征,以便为UA的合理利用和药物设计提供参考。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号